comprehensive -WSS

comprehensive

author：leisure time 2025-09-10 08:21:44 - browse：95

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： When waiting feels immoral: Empathy in the emergency department

WSS

'Null' research findings aren't empty of meaning. Let's publish them

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Roche's accidental data boosts hopes for anti

Trans patients at the end of life deserve respect and dignity

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Trans patients at the end of life deserve respect and dignity

focus

comprehensive

knowledge

Sports medicine is finally prioritizing gender equality

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Medical leaders decry Supreme Court decision on affirmative action

Health officials lay out plans to cope with respiratory virus season

Duchenne breakthrough therapy leaves behind pioneering families

CDC says it’s too soon to assess risk posed by Covid subvariant

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wegovy improves function in certain heart failure patients

Hollywood unions extend contract negotiations for actors

It costs an awful lot of money to give away a kidney

entertainment

Wegovy improves function in certain heart failure patients

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

FDA scientists endorse Pfizer/BioNTech Covid

The cancer stories no one wants to hear

As obesity drug market grows, telehealth companies court payers

focus

hotspot

entertainment

focus